Advertisement

Topics

CET CANCER CENTER Company Profile

08:23 EDT 21st September 2018 | BioPortfolio

California Endocurietherapy Cancer Center (CET) is the first brachytherapy only center in the United States.
Founded by D Jeffrey Demanes M.D. in 1981.
Dedicated solely to High Dose Rate brachytherapy (HDR) since 1991.
Most experienced HDR brachytherapy center.
A training destination for physicians and residents.
HDR treatment protocol development
Innovation in high dose rate brachytherapy and equipment design
Dedicated to long-term follow-up, outcome studies, and publications in medical journals.

Location

California Endocurietherapy Medical Corp.3012 Summit St. Suite 2675
Oakland
California
94609
United States of America

Contact

Phone: 510-986-0690
Fax: 510-986-0159
Email: askcet@cetmc.com


News Articles [2756 Associated News Articles listed on BioPortfolio]

UH Cancer Center renews NCI designation

(University of Hawaii Cancer Center) The University of Hawai'i Cancer Center successfully competed for renewal of National Cancer Institute (NCI) designation, and has been awarded a $6 million Cancer ...

Florida Cancer Centers awarded $1.36 million to fight pancreatic cancer

(H. Lee Moffitt Cancer Center & Research Institute) The Florida Department of Health's James and Esther King Biomedical Research Program has armed Moffitt Cancer Center, University of Florida (UF) Hea...

UH Cancer Center partners with nation's top cancer centers to endorse goal

(University of Hawaii Cancer Center) University of Hawai'i Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging for increased...

Okla. cancer center advances multiple immunotherapy, CAR-T therapy trials

The Stephenson Cancer Center in Oklahoma City was recognized in March by the National Clinical Trials Network as the center t -More- 

YCC launches new Yale Center for Immuno-Oncology

Yale Cancer Center has launched the Yale Center for Immuno-Oncology. The new center will build on YCC's international leadership in immunobiology, cancer immunology, and development of novel cancer im...

KU Cancer Center to present evidence supporting anti-cancer drug at AACR 2018

The University of Kansas Cancer Center will present preclinical evidence supporting Ciclopirox Prodrug (CPX-POM), an anti-cancer agent currently in Phase I clinical trials, at the American Association...

Case comprehensive cancer center endorses elimination of HPV-related cancers

(Case Western Reserve University) Case Comprehensive Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging increased HPV vacci...

MD Anderson Therapeutics Discovery team identifies and advances a drug that targets metabolic vulnerability and impairs cancer cell growth and survival

(University of Texas M. D. Anderson Cancer Center) A drug discovered and advanced by The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science (IACS) and the Center for ...

PubMed Articles [6614 Associated PubMed Articles listed on BioPortfolio]

Burden of cardiovascular disease in Japanese cancer patients and survivors: a single cancer-center study in Niigata City.

Cardiovascular disease (CVD) and cancer are major causes of death in Japan. As most CVDs are chronic and often aggravate, long-term follow-up is necessary. Although some cancer patients and survivors ...

Head and Neck Cancer in World Trade Center Responders: A Case Series.

To report on cases of head and neck cancer (HNC) among World Trade Center (WTC) responders participating in the WTC Health Program and seen at Rutgers WTC Center of Clinical Excellence.

End-of-Life Treatments in Pediatric Patients at a Government Tertiary Cancer Center in India.

The primary objective of this study was to describe demographics and end-of-life treatments of children with cancer at a government tertiary cancer center in India.

Oncologic emergencies in a cancer center emergency department and in general emergency departments countywide and nationwide.

Although cancer patients (CPs) are increasingly likely to visit emergency department (ED), no population-based study has compared the characteristics of CPs and non-cancer patients (NCPs) who visit th...

Characteristics and Outcomes of Advanced Cancer Patients Who Received Palliative Care at a Public Hospital Compared with Those at a Comprehensive Cancer Center.

Patients with advanced cancer experience severe physical, psychosocial, and spiritual distress requiring palliative care (PC). There are limited literature regarding characteristics and outcomes of pa...

Clinical Trials [10433 Associated Clinical Trials listed on BioPortfolio]

Simultaneous Care: Linking Palliation to Clinical Trials

This is a multi-site randomized control trial taking place at six cancer centers. UC Davis is the lead site. Additional performance sites include the City of Hope Medical Center, Fred Hut...

Analysis of Neurocognitive Elements of Attention After Chemotherapy

Data for this study will be obtained from the University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center. Participants will be recruited through Simmons Cancer Cen...

Reducing Disparities in Rural Advanced Cancer Patients and Caregivers

The Purpose of this project is to implement ENABLE (Educate, Nurture, Advise, Before Life Ends) at four community cancer practices that have a high percentage of rural and/or medically-und...

Cancer Occurrence and Outcome in Young Patients Undergoing Cancer Treatment at the Vanderbilt-Ingram Cancer Center

RATIONALE: Gathering information about the number of young patients with cancer and the outcome of these patients may help doctors learn more about cancer. PURPOSE: This research study is...

Measurement of Cancer-Related Risk Perception in Smokers

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Cen...

Companies [2742 Associated Companies listed on BioPortfolio]

H. Lee Moffitt Cancer Center & Research Institute

Located in Tampa, Florida, Moffitt Cancer Center (www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and ...

John Theurer Cancer Center at Hackensack University Medical Center

John Theurer Cancer Center at Hackensack University Medical Center is among the nation’s top 50 U.S. News and World Report Best Hospitals for Cancer – the highest ranked...

Advanced Cancer Therapeutics (ACT)

ACT is a for-profit private company dedicated to advancing novel therapeutics for the prevention and treatment of cancer. ACT has successfully established a unique and innovative ...

Moffitt Cancer Center

Located in Tampa, Florida, Moffitt Cancer Center is an NCI Comprehensive Cancer Center - a designation that recognizes Moffitt’s excellence in research and contributio...

Capital Breast Cancer Center

The Lombardi Comprehensive Cancer Center, part of Georgetown University Medical Center and Georgetown University Hospital, seeks to improve the diagnosis, treatment, and prevention of cancer through i...

More Information about "CET CANCER CENTER" on BioPortfolio

We have published hundreds of CET CANCER CENTER news stories on BioPortfolio along with dozens of CET CANCER CENTER Clinical Trials and PubMed Articles about CET CANCER CENTER for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CET CANCER CENTER Companies in our database. You can also find out about relevant CET CANCER CENTER Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record